APO Research
Talk to an analyst

APO RESEARCH · REPORT

Niraparib Preparations

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Niraparib Preparations Market Analysis and Forecast 2026-2032

29 December 2025197 pages

Choose your research edition.

Industry ResearchNiraparib Preparations Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Niraparib Preparations Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Niraparib Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niraparib Preparations Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Niraparib Preparations Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Niraparib Preparations market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Niraparib Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Niraparib Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Niraparib Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Niraparib Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Niraparib Preparations include Zai Lab, Takeda Pharmaceutical, Janssen Biotech and GSK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Niraparib Preparations, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Niraparib Preparations, also provides the sales of main regions and countries. Of the upcoming market potential for Niraparib Preparations, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Niraparib Preparations sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Niraparib Preparations market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Niraparib Preparations sales, projected growth trends, production technology, application and end-user industry.

Niraparib Preparations Segment by Company

Zai Lab

Takeda Pharmaceutical

Janssen Biotech

GSK

Niraparib Preparations Segment by Type

Single Drug

Combination Preparation

Niraparib Preparations Segment by Application

Ovarian Cancer

Prostate Cancer

Primary Peritoneal Cancer

Other

Niraparib Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niraparib Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Niraparib Preparations in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Niraparib Preparations manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Niraparib Preparations sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Niraparib Preparations Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Drug Major Manufacturers Table 3. Combination Preparation Major Manufacturers Table 4. Global Niraparib Preparations Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Ovarian Cancer Major Manufacturers Table 6. Prostate Cancer Major Manufacturers Table 7. Primary Peritoneal Cancer Major Manufacturers Table 8. Other Major Manufacturers Table 9. Niraparib Preparations Industry Trends Table 10. Niraparib Preparations Industry Drivers Table 11. Niraparib Preparations Industry Opportunities and Challenges Table 12. Niraparib Preparations Industry Restraints Table 13. Global Niraparib Preparations Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Niraparib Preparations Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Niraparib Preparations Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Niraparib Preparations Revenue Market Share by Region (2021-2026) Table 17. Global Niraparib Preparations Revenue Market Share by Region (2027-2032) Table 18. Global Niraparib Preparations Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Niraparib Preparations Sales by Region (2021-2026) & (K Units) Table 20. Global Niraparib Preparations Sales by Region (2027-2032) & (K Units) Table 21. Global Niraparib Preparations Sales Market Share by Region (2021-2026) Table 22. Global Niraparib Preparations Sales Market Share by Region (2027-2032) Table 23. Global Niraparib Preparations Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Niraparib Preparations Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Niraparib Preparations Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Niraparib Preparations Sales Market Share by Manufacturers (2021-2026) Table 27. Global Niraparib Preparations Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Niraparib Preparations Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Niraparib Preparations Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Niraparib Preparations Manufacturers, Product Type & Application Table 31. Global Niraparib Preparations Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Niraparib Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Niraparib Preparations Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Niraparib Preparations Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Niraparib Preparations Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Niraparib Preparations Revenue Market Share by Type (2021-2026) Table 38. Global Niraparib Preparations Revenue Market Share by Type (2027-2032) Table 39. Global Niraparib Preparations Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 41. Global Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 42. Global Niraparib Preparations Sales Market Share by Type (2021-2026) Table 43. Global Niraparib Preparations Sales Market Share by Type (2027-2032) Table 44. Global Niraparib Preparations Price by Type (2021-2026) & (US$/Unit) Table 45. Global Niraparib Preparations Price by Type (2027-2032) & (US$/Unit) Table 46. Global Niraparib Preparations Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Niraparib Preparations Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Niraparib Preparations Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Niraparib Preparations Revenue Market Share by Application (2021-2026) Table 50. Global Niraparib Preparations Revenue Market Share by Application (2027-2032) Table 51. Global Niraparib Preparations Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 53. Global Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 54. Global Niraparib Preparations Sales Market Share by Application (2021-2026) Table 55. Global Niraparib Preparations Sales Market Share by Application (2027-2032) Table 56. Global Niraparib Preparations Price by Application (2021-2026) & (US$/Unit) Table 57. Global Niraparib Preparations Price by Application (2027-2032) & (US$/Unit) Table 58. Zai Lab Company Information Table 59. Zai Lab Business Overview Table 60. Zai Lab Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zai Lab Niraparib Preparations Product Portfolio Table 62. Zai Lab Recent Development Table 63. Takeda Pharmaceutical Company Information Table 64. Takeda Pharmaceutical Business Overview Table 65. Takeda Pharmaceutical Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceutical Niraparib Preparations Product Portfolio Table 67. Takeda Pharmaceutical Recent Development Table 68. Janssen Biotech Company Information Table 69. Janssen Biotech Business Overview Table 70. Janssen Biotech Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Janssen Biotech Niraparib Preparations Product Portfolio Table 72. Janssen Biotech Recent Development Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Niraparib Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GSK Niraparib Preparations Product Portfolio Table 77. GSK Recent Development Table 78. North America Niraparib Preparations Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Niraparib Preparations Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 81. North America Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 82. North America Niraparib Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 83. North America Niraparib Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 84. North America Niraparib Preparations Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Niraparib Preparations Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 87. North America Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 88. North America Niraparib Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 89. North America Niraparib Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 90. North America Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Niraparib Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Niraparib Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 94. North America Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 95. North America Niraparib Preparations Sales by Country (2027-2032) & (K Units) Table 96. North America Niraparib Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 97. North America Niraparib Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 98. United States Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 99. Canada Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 100. Mexico Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 101. Europe Niraparib Preparations Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Niraparib Preparations Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 104. Europe Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 105. Europe Niraparib Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 106. Europe Niraparib Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 107. Europe Niraparib Preparations Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Niraparib Preparations Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 110. Europe Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 111. Europe Niraparib Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 112. Europe Niraparib Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 113. Europe Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Niraparib Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Niraparib Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 117. Europe Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 118. Europe Niraparib Preparations Sales by Country (2027-2032) & (K Units) Table 119. Europe Niraparib Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 120. Europe Niraparib Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 121. Germany Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 122. France Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 123. U.K. Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 124. Italy Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 125. Russia Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 126. Spain Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 128. Switzerland Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 129. Sweden Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 130. Poland Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 131. China Niraparib Preparations Revenue by Type (2021-2026) & (US$ Million) Table 132. China Niraparib Preparations Revenue by Type (2027-2032) & (US$ Million) Table 133. China Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 134. China Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 135. China Niraparib Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 136. China Niraparib Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 137. China Niraparib Preparations Revenue by Application (2021-2026) & (US$ Million) Table 138. China Niraparib Preparations Revenue by Application (2027-2032) & (US$ Million) Table 139. China Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 140. China Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 141. China Niraparib Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 142. China Niraparib Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Niraparib Preparations Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Niraparib Preparations Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 146. Asia Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 147. Asia Niraparib Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Asia Niraparib Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Asia Niraparib Preparations Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Niraparib Preparations Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 152. Asia Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 153. Asia Niraparib Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Asia Niraparib Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Asia Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Niraparib Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Niraparib Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Asia Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 160. Asia Niraparib Preparations Sales by Country (2027-2032) & (K Units) Table 161. Asia Niraparib Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Asia Niraparib Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Japan Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 164. South Korea Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 165. India Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 166. Australia Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 167. Taiwan Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Niraparib Preparations Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Niraparib Preparations Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Niraparib Preparations Sales by Type (2021-2026) & (K Units) Table 172. SAMEA Niraparib Preparations Sales by Type (2027-2032) & (K Units) Table 173. SAMEA Niraparib Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 174. SAMEA Niraparib Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 175. SAMEA Niraparib Preparations Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Niraparib Preparations Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Niraparib Preparations Sales by Application (2021-2026) & (K Units) Table 178. SAMEA Niraparib Preparations Sales by Application (2027-2032) & (K Units) Table 179. SAMEA Niraparib Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 180. SAMEA Niraparib Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 181. SAMEA Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Niraparib Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Niraparib Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. SAMEA Niraparib Preparations Sales by Country (2021-2026) & (K Units) Table 186. SAMEA Niraparib Preparations Sales by Country (2027-2032) & (K Units) Table 187. SAMEA Niraparib Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 188. SAMEA Niraparib Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Brazil Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 190. Argentina Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 191. Chile Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 192. Colombia Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 193. Peru Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 195. Israel Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 196. UAE Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 197. Turkey Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 198. Iran Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 199. Egypt Niraparib Preparations Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Niraparib Preparations Distributors List Table 203. Niraparib Preparations Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Niraparib Preparations Image Figure 2. Global Niraparib Preparations Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niraparib Preparations Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Drug Image Figure 5. Combination Preparation Image Figure 6. Global Niraparib Preparations Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Niraparib Preparations Market Size Share 2021 VS 2025 VS 2032 Figure 8. Ovarian Cancer Image Figure 9. Prostate Cancer Image Figure 10. Primary Peritoneal Cancer Image Figure 11. Other Image Figure 12. Global Niraparib Preparations Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Niraparib Preparations Revenue (2021-2032) & (US$ Million) Figure 14. Global Niraparib Preparations Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Niraparib Preparations Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Niraparib Preparations Revenue Market Share by Region (2021-2032) Figure 17. Global Niraparib Preparations Sales (2021-2032) & (K Units) Figure 18. Global Niraparib Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Niraparib Preparations Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Niraparib Preparations Sales YoY (2021-2032) & (K Units) Figure 21. Europe Niraparib Preparations Sales YoY (2021-2032) & (K Units) Figure 22. China Niraparib Preparations Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Niraparib Preparations Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Niraparib Preparations Sales YoY (2021-2032) & (K Units) Figure 25. Global Niraparib Preparations Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Niraparib Preparations Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Niraparib Preparations Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Niraparib Preparations Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Niraparib Preparations Revenue Market Share by Type (2021-2032) Figure 31. Global Niraparib Preparations Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Niraparib Preparations Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Niraparib Preparations Sales Market Share by Type (2021-2032) Figure 34. Global Niraparib Preparations Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Niraparib Preparations Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Niraparib Preparations Revenue Market Share by Application (2021-2032) Figure 37. Global Niraparib Preparations Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Niraparib Preparations Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Niraparib Preparations Sales Market Share by Application (2021-2032) Figure 40. North America Niraparib Preparations Revenue Share by Type (2021-2032) Figure 41. North America Niraparib Preparations Sales Share by Type (2021-2032) Figure 42. North America Niraparib Preparations Revenue Share by Application (2021-2032) Figure 43. North America Niraparib Preparations Sales Share by Application (2021-2032) Figure 44. North America Niraparib Preparations Revenue Share by Country (2021-2032) Figure 45. North America Niraparib Preparations Sales Share by Country (2021-2032) Figure 46. Europe Niraparib Preparations Revenue Share by Type (2021-2032) Figure 47. Europe Niraparib Preparations Sales Share by Type (2021-2032) Figure 48. Europe Niraparib Preparations Revenue Share by Application (2021-2032) Figure 49. Europe Niraparib Preparations Sales Share by Application (2021-2032) Figure 50. Europe Niraparib Preparations Revenue Share by Country (2021-2032) Figure 51. Europe Niraparib Preparations Sales Share by Country (2021-2032) Figure 52. China Niraparib Preparations Revenue Share by Type (2021-2032) Figure 53. China Niraparib Preparations Sales Share by Type (2021-2032) Figure 54. China Niraparib Preparations Revenue Share by Application (2021-2032) Figure 55. China Niraparib Preparations Sales Share by Application (2021-2032) Figure 56. Asia Niraparib Preparations Revenue Share by Type (2021-2032) Figure 57. Asia Niraparib Preparations Sales Share by Type (2021-2032) Figure 58. Asia Niraparib Preparations Revenue Share by Application (2021-2032) Figure 59. Asia Niraparib Preparations Sales Share by Application (2021-2032) Figure 60. Asia Niraparib Preparations Revenue Share by Country (2021-2032) Figure 61. Asia Niraparib Preparations Sales Share by Country (2021-2032) Figure 62. SAMEA Niraparib Preparations Revenue Share by Type (2021-2032) Figure 63. SAMEA Niraparib Preparations Sales Share by Type (2021-2032) Figure 64. SAMEA Niraparib Preparations Revenue Share by Application (2021-2032) Figure 65. SAMEA Niraparib Preparations Sales Share by Application (2021-2032) Figure 66. SAMEA Niraparib Preparations Revenue Share by Country (2021-2032) Figure 67. SAMEA Niraparib Preparations Sales Share by Country (2021-2032) Figure 68. Niraparib Preparations Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Niraparib Preparations Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Ovarian Cancer
  • Prostate Cancer
  • Primary Peritoneal Cancer
  • Other
Companies covered
  • Zai Lab
  • Takeda Pharmaceutical
  • Janssen Biotech
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Niraparib Preparations Market by Type
  3. 1.2.1 Global Niraparib Preparations Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Drug
  5. 1.2.3 Combination Preparation
  6. 1.3 Niraparib Preparations Market by Application
  7. 1.3.1 Global Niraparib Preparations Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Ovarian Cancer
  9. 1.3.3 Prostate Cancer
  10. 1.3.4 Primary Peritoneal Cancer
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Niraparib Preparations Market Dynamics
  1. 2.1 Niraparib Preparations Industry Trends
  2. 2.2 Niraparib Preparations Industry Drivers
  3. 2.3 Niraparib Preparations Industry Opportunities and Challenges
  4. 2.4 Niraparib Preparations Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Niraparib Preparations Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Niraparib Preparations Revenue by Region
  3. 3.2.1 Global Niraparib Preparations Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Niraparib Preparations Revenue by Region (2021-2026)
  5. 3.2.3 Global Niraparib Preparations Revenue by Region (2027-2032)
  6. 3.2.4 Global Niraparib Preparations Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Niraparib Preparations Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Niraparib Preparations Sales by Region
  9. 3.4.1 Global Niraparib Preparations Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Niraparib Preparations Sales by Region (2021-2026)
  11. 3.4.3 Global Niraparib Preparations Sales by Region (2027-2032)
  12. 3.4.4 Global Niraparib Preparations Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Niraparib Preparations Revenue by Manufacturers
  2. 4.1.1 Global Niraparib Preparations Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Niraparib Preparations Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Niraparib Preparations Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Niraparib Preparations Sales by Manufacturers
  6. 4.2.1 Global Niraparib Preparations Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Niraparib Preparations Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Niraparib Preparations Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Niraparib Preparations Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Niraparib Preparations Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Niraparib Preparations Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Niraparib Preparations Manufacturers, Product Type & Application
  13. 4.7 Global Niraparib Preparations Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Niraparib Preparations Market CR5 and HHI
  16. 4.8.2 2025 Niraparib Preparations Tier 1, Tier 2, and Tier 3
5 Niraparib Preparations Market by Type
  1. 5.1 Global Niraparib Preparations Revenue by Type
  2. 5.1.1 Global Niraparib Preparations Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Niraparib Preparations Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Niraparib Preparations Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Niraparib Preparations Sales by Type
  6. 5.2.1 Global Niraparib Preparations Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Niraparib Preparations Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Niraparib Preparations Sales Market Share by Type (2021-2032)
  9. 5.3 Global Niraparib Preparations Price by Type
6 Niraparib Preparations Market by Application
  1. 6.1 Global Niraparib Preparations Revenue by Application
  2. 6.1.1 Global Niraparib Preparations Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Niraparib Preparations Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Niraparib Preparations Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Niraparib Preparations Sales by Application
  6. 6.2.1 Global Niraparib Preparations Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Niraparib Preparations Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Niraparib Preparations Sales Market Share by Application (2021-2032)
  9. 6.3 Global Niraparib Preparations Price by Application
7 Company Profiles
  1. 7.1 Zai Lab
  2. 7.1.1 Zai Lab Company Information
  3. 7.1.2 Zai Lab Business Overview
  4. 7.1.3 Zai Lab Niraparib Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zai Lab Niraparib Preparations Product Portfolio
  6. 7.1.5 Zai Lab Recent Developments
  7. 7.2 Takeda Pharmaceutical
  8. 7.2.1 Takeda Pharmaceutical Company Information
  9. 7.2.2 Takeda Pharmaceutical Business Overview
  10. 7.2.3 Takeda Pharmaceutical Niraparib Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Pharmaceutical Niraparib Preparations Product Portfolio
  12. 7.2.5 Takeda Pharmaceutical Recent Developments
  13. 7.3 Janssen Biotech
  14. 7.3.1 Janssen Biotech Company Information
  15. 7.3.2 Janssen Biotech Business Overview
  16. 7.3.3 Janssen Biotech Niraparib Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Janssen Biotech Niraparib Preparations Product Portfolio
  18. 7.3.5 Janssen Biotech Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Niraparib Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GSK Niraparib Preparations Product Portfolio
  24. 7.4.5 GSK Recent Developments
8 North America
  1. 8.1 North America Niraparib Preparations Market Size by Type
  2. 8.1.1 North America Niraparib Preparations Revenue by Type (2021-2032)
  3. 8.1.2 North America Niraparib Preparations Sales by Type (2021-2032)
  4. 8.1.3 North America Niraparib Preparations Price by Type (2021-2032)
  5. 8.2 North America Niraparib Preparations Market Size by Application
  6. 8.2.1 North America Niraparib Preparations Revenue by Application (2021-2032)
  7. 8.2.2 North America Niraparib Preparations Sales by Application (2021-2032)
  8. 8.2.3 North America Niraparib Preparations Price by Application (2021-2032)
  9. 8.3 North America Niraparib Preparations Market Size by Country
  10. 8.3.1 North America Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Niraparib Preparations Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Niraparib Preparations Market Size by Type
  2. 9.1.1 Europe Niraparib Preparations Revenue by Type (2021-2032)
  3. 9.1.2 Europe Niraparib Preparations Sales by Type (2021-2032)
  4. 9.1.3 Europe Niraparib Preparations Price by Type (2021-2032)
  5. 9.2 Europe Niraparib Preparations Market Size by Application
  6. 9.2.1 Europe Niraparib Preparations Revenue by Application (2021-2032)
  7. 9.2.2 Europe Niraparib Preparations Sales by Application (2021-2032)
  8. 9.2.3 Europe Niraparib Preparations Price by Application (2021-2032)
  9. 9.3 Europe Niraparib Preparations Market Size by Country
  10. 9.3.1 Europe Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Niraparib Preparations Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Niraparib Preparations Market Size by Type
  2. 10.1.1 China Niraparib Preparations Revenue by Type (2021-2032)
  3. 10.1.2 China Niraparib Preparations Sales by Type (2021-2032)
  4. 10.1.3 China Niraparib Preparations Price by Type (2021-2032)
  5. 10.2 China Niraparib Preparations Market Size by Application
  6. 10.2.1 China Niraparib Preparations Revenue by Application (2021-2032)
  7. 10.2.2 China Niraparib Preparations Sales by Application (2021-2032)
  8. 10.2.3 China Niraparib Preparations Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Niraparib Preparations Market Size by Type
  2. 11.1.1 Asia Niraparib Preparations Revenue by Type (2021-2032)
  3. 11.1.2 Asia Niraparib Preparations Sales by Type (2021-2032)
  4. 11.1.3 Asia Niraparib Preparations Price by Type (2021-2032)
  5. 11.2 Asia Niraparib Preparations Market Size by Application
  6. 11.2.1 Asia Niraparib Preparations Revenue by Application (2021-2032)
  7. 11.2.2 Asia Niraparib Preparations Sales by Application (2021-2032)
  8. 11.2.3 Asia Niraparib Preparations Price by Application (2021-2032)
  9. 11.3 Asia Niraparib Preparations Market Size by Country
  10. 11.3.1 Asia Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Niraparib Preparations Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Niraparib Preparations Market Size by Type
  2. 12.1.1 SAMEA Niraparib Preparations Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Niraparib Preparations Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Niraparib Preparations Price by Type (2021-2032)
  5. 12.2 SAMEA Niraparib Preparations Market Size by Application
  6. 12.2.1 SAMEA Niraparib Preparations Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Niraparib Preparations Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Niraparib Preparations Price by Application (2021-2032)
  9. 12.3 SAMEA Niraparib Preparations Market Size by Country
  10. 12.3.1 SAMEA Niraparib Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Niraparib Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Niraparib Preparations Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Niraparib Preparations Value Chain Analysis
  2. 13.1.1 Niraparib Preparations Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Niraparib Preparations Production Mode & Process
  6. 13.2 Niraparib Preparations Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Niraparib Preparations Distributors
  9. 13.2.3 Niraparib Preparations Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst